USE OF ICARITIN FOR OBTAINING MEDICINAL PRODUCTS Russian patent published in 2023 - IPC A61K31/352 A61P7/04 

FIELD: medicine; therapy; hematology.

SUBSTANCE: group of inventions is intended for the prevention and treatment of hemorrhagic diseases. Icaritin is used to prepare medicinal products intended for the prevention and treatment of hemorrhagic diseases, which are platelet dysfunction, hemorrhagic diseases caused by it, hemorrhagic diseases caused by blood clotting disorders, hemorrhagic diseases caused by abnormalities in the walls of blood vessels, or hemorrhagic diseases caused by anticoagulants and fibrinolysis, wherein said platelet dysfunction is a disorder of platelet activation or aggregation, and the hemorrhagic disease is caused by hemorrhagic transformation of cerebral infarction, gastrointestinal bleeding caused by the use of thrombolytic or antithrombotic drugs in the treatment of cerebral infarction, or hemorrhagic complications caused by the use of thrombolytic or antithrombotic drugs drugs in the treatment of myocardial infarction. The following is also presented: the use of icaritin in the prevention or treatment of a hemorrhagic disease in a patient, including the step of administering icaritin at a dose of 0.01–100 mg/kg to the patient.

EFFECT: use of a group of inventions ensures effective prevention and treatment of hemorrhagic diseases.

19 cl, 19 tbl, 21 ex